Trials / Unknown
UnknownNCT04622826
plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients
Studio in Aperto Sulla Somministrazione di Plasma di Paziente Convalescente da COVID- 19 a Paziente Con Polmonite COVID-19 Ospedalizzato, Non in Terapia Intensiva
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Azienda USL Toscana Nord Ovest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of the study is to verify the efficacy and safety of convalescent hyperimmune plasma infusion in hospitalized covid-19 patients non in ITU with pneumonia and respiratory symptoms within seven days from the beginning of symptoms. Efficacy is evaluated by the number of patients who will improve their clinical condition and will not be admitted to ITU. .Safety is considered in relation to adverse reactions to plasma infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | immune plasma | immune covid 19 plasma infusion |
Timeline
- Start date
- 2020-05-15
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2020-11-10
- Last updated
- 2020-11-10
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04622826. Inclusion in this directory is not an endorsement.